Hemoglobinopathy Nursing Program and Pediatric Nursing Students

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-27

Study Completion Date

2017-05-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hemoglobinopathies are the most common life threatening, monogenic disorders in the world. The most common causes of hemoglobinopathies are sickle cell disease and thalassemia. Aim: This study aimed to evaluate the effect of a hemoglobinopathy nursing program on pediatric nursing students' performance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Nonpharmacological Approaches and Parental Education in Children With Sickle Cell Disease

NCT04121247

Nursing Caries

COMPLETED NA

Dermatological Abnormalities in Beta-thalassemia Major

NCT03894605

Beta-Thalassemia

UNKNOWN

Assessment of Cognitive Function and Quality of Life in Thalassemic Children at Sohag University Hospital

NCT06058260

Thalassemia

UNKNOWN

Pilates Physical Activity in Sickle Cell Disease

NCT05519852

Sickle Cell Disease

UNKNOWN NA

Genetic Profile of Alpha Thalassemia Children at Sohag University Hospital .

NCT06591936

Alpha-Thalassemia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemoglobinopathies Thalassemia Sickle Cell Disease Nurse's Role

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Experimental Group (n=54) The implementation phase was achieved through sessions within Feb-April2017 second semester of the academic year 2016/2017.Each session started by the objectives of the new session and summary of previous one. Motivation and reinforcement during session were used to enhance participation and sharing in this study. The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.

Group Type EXPERIMENTAL

Hemoglobinopathy Nursing Program

Intervention Type OTHER

"Hemoglobinopathy Nursing Program" is more informative for "Groupe 1" than "Group 2"

Group 2

Control Group (n=54) The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.

Group Type NO_INTERVENTION

No interventions assigned to this group